Hypermobility and EDS Treatment in Marylebone, London
Hypermobility and EDS care in Marylebone, London for the pain, fatigue and fog that come with it, rather than for the joints themselves. The direct evidence for magnetic stimulation in hypermobile EDS is early, and we will say so before you spend anything.
Overview
Understanding hypermobility and EDS
If you have hypermobile Ehlers-Danlos syndrome or hypermobility spectrum disorder, you have probably spent years being told your tests are normal. They often are. The connective tissue is the difference, and it does not show up on the scans people order first.
What brings most people here is not the joints. It is what has built on top of them: pain that has spread beyond the joint that started it, fatigue that activity makes worse, dizziness on standing, and a fog that makes work harder than it should be.
The mechanism that links those is central sensitisation. When a nervous system takes years of pain input, it can settle into a heightened state of reactivity, so signals get amplified and ordinary sensations start to register as painful. At that point the tissue is no longer the whole story, and treating the nervous system becomes reasonable.
Where the evidence actually stands. We are not aware of a randomised controlled trial of rTMS in hypermobile EDS. That is the plain truth and you should weigh it. What exists is evidence in the symptoms that travel alongside: the international consensus guidelines published by Lefaucheur and colleagues in Clinical Neurophysiology in 2020 support high-frequency stimulation of the motor cortex in neuropathic pain, and the evidence in fatigue is earlier and smaller again. Whether that transfers to your presentation is a judgement, not a certainty, and your clinician will treat it as one.
Diagnosis of hEDS or hypermobility spectrum disorder is not something we do. That sits with rheumatology and specialist services. If you are undiagnosed, start with your GP.
Why it happens
What causes hypermobility and EDS?
-
Heritable differences in connective tissue, which allow joints to move beyond the usual range
-
Repeated joint subluxation, dislocation and soft-tissue injury, producing years of pain input
-
Central sensitisation, in which the nervous system stays in a heightened state of reactivity and amplifies pain signals
-
Autonomic dysfunction affecting heart rate and blood pressure control, which drives the dizziness and much of the fatigue
-
Deconditioning that follows when pain makes activity unpredictable
-
Poor sleep from night pain, which lowers pain threshold the following day
Treatment approach
How we treat hypermobility symptoms in Marylebone
NayaScore assessment
On enquiryHypermobility is the condition most likely to have been dismissed on the basis of normal tests, so having your own numbers matters. NayaScore records grip strength, continuous heart rate variability from a wearable ring, and cognitive testing across twelve domains. It is a measurement tool rather than a diagnostic test, and results are interpreted alongside clinical judgement.
See treatment detail →Precision rTMS
From £350 a sessionWhere pain has become widespread and central sensitisation is part of the picture, stimulation targets the nervous system rather than the joint. The evidence in hypermobile EDS specifically is early, and the stronger evidence sits in neuropathic pain, so this is offered as a considered option and not as an established treatment.
See treatment detail →Heart-brain coupling
On enquiryAutonomic regulation is often affected in hypermobility, which makes choosing the target by measurement rather than by an average scalp coordinate more relevant, not less. Candidate sites are tested and the one producing the clearest slowing of your heart rate is treated.
See treatment detail →Integrated therapy
On enquiryYears of being disbelieved leaves its own mark, and pacing is a skill rather than an instruction. Psychological support here addresses that directly, and it sits alongside the physiotherapy and joint-stability work that remains central to managing hypermobility.
See treatment detail →Restore programme
From £350 a sessionRestore is the pathway for people below their own baseline with a diagnosed condition. It sets the course length, the review points and the measures at the start, which is the opposite of the open-ended search most people with hypermobility have already been through.
See treatment detail →Progress tracking
On enquirySymptoms in hypermobility flare and settle for reasons that have nothing to do with treatment. Repeating the same measures across a course is what separates a real trend from a good fortnight, and it is how we decide whether to continue or stop.
See treatment detail →FAQ
Hypermobility and EDS questions
Is there real evidence for rTMS in hypermobility or EDS?
Not directly, and we will not pretend otherwise. We are not aware of a randomised controlled trial in hypermobile EDS. The evidence sits in the symptoms alongside it, mainly chronic and neuropathic pain, where the Lefaucheur consensus guidelines of 2020 support motor cortex stimulation. Treat this as an early option, not an established one.
Can you diagnose my hypermobility or EDS?
No. Diagnosis of hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder sits with rheumatology and specialist services, and it is a clinical assessment rather than a scan. Start with your GP if you are undiagnosed. We work on the pain, fatigue and cognitive symptoms once that picture is clearer.
Will this help my joints or my dislocations?
No. Magnetic stimulation does not change connective tissue and it will not stabilise a joint. Physiotherapy, strength work and joint protection remain the core of managing that, and they should continue. What stimulation targets is the nervous system side: amplified pain signalling, fatigue and cognitive symptoms.
I get dizzy standing up. Is that relevant here?
Yes, and it should be assessed properly. Dizziness and a racing heart on standing can indicate postural tachycardia syndrome, which often accompanies hypermobility and belongs with cardiology or an autonomic service. Tell us at the consultation. We measure heart rate variability continuously, but we do not manage PoTS.
How will I know if it is working?
By repeating the same measures. Your baseline covers grip strength, heart rate variability and twelve cognitive domains, and it is reassessed during the course rather than only at the end. If the numbers are not moving, we tell you and stop, instead of selling you the next block.
Related What we treat
Get Started
Ready to begin?
Book today.
Naya • 1 Orchard Street, London W1H 6HJ
BookAppointments typically available within 1–2 weeks